BCPPs desiring a case-based learning activity at the specialist level focused on a complex patient case intertwined with comorbid medical diagnoses and contemporary issues in psychiatric pharmacy are the intended audience of this recertification activity. BCPPs who are auditory and visual learners and/or who learn best from practical application to a patient case mirroring real-life scenarios will find value in this course. BCPPs responsible for teaching/precepting others also note the value of this product long after completing it for their personal learning.
Content
From Theory to Practice Case Series is an application-based continuing pharmacy education (CPE) activity that provides the opportunity to study a complex psychiatric patient case, often comorbid with a medical diagnosis and associated complex medication regimen. A patient is followed over three encounters with each one consisting of a case study, pre-recorded webinar, and self-assessment questions. This edition is focused on weight gain with antipsychotics.
The activity design allows for the opportunity to apply evidence-based pharmacologic and/or non-pharmacologic treatment strategies and monitoring recommendations specific to patient needs and any pertinent medical, psychosocial, family, cultural, and socioeconomic issues. Instructional webinars extend the value of the activity long after completion.
An application-based CPE activity requires that participants apply the information learned. In an application-based CPE activity, the learning objectives are written at a higher level in order to assess the learner's ability to use the information that is learned, at the expected level of practice of Board Certified Psychiatric Pharmacists. The examination for this product often features cases requiring that the participant apply the principles learned through the encounters.
The From Theory to Practice Case Series includes electronic access to:
A complex patient case consisting of 3 encounters over a period of time.
Three instructional, pre-recorded webinars accompanying each encounter.
Five (5) hours of ACPE credit and 5 hours of BCPP Recertification credit, achieved by successfully completing the online AAPP recertification examination. ACPE credit is reported to CPE Monitor at nabp.net within 48 hours after successful completion of the examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed (2024 or 2025).
Access to the AAPP testing center with exam submission due by March 27, 2025
IMPORTANT NOTE: Since this product involves progression through a patient case over a period of time, it is highly recommended by the Editorial Board and past users, that you carve out 5 hours for the course and complete all in 1 sitting.
Consider making this product part of your BPS Continuing Professional Development plan! Please refer to the BPS Psychiatric Pharmacy Content Outline to see how this activity may align.
Course Requirements
To satisfactorily complete the From Theory to Practice Case and receive 5 hours of BCPP Recertification and ACPE credit, candidates must meet the following requirements:
Abide by a confidentiality and honesty statement requiring individual completion of the recertification education.
Successfully complete an online examination on or before the deadline of March 27, 2025.
Meet the minimum passing score (72%) on the final examination as determined by a panel of experts.
Complete the examination at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
Wait for the official review of exam questions within 4 weeks following the closing date.
Be notified of your grade and gain access to your exam results and feedback.
Receive a passing grade (as determined by a panel of experts within 4 weeks following the closing date).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Credit is awarded in the calendar year the assessment is completed. AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended,
or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat
or FoxIt
An adequate device and Internet connection:
Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent);
Memory: 4 GB;
Storage: 5 GB available;
Internet speed: 4.0 Mbps (up/down)
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: albiglutide, bupropion-naltrexone, dulaglutide, exenatide, 1uraglutide, lixisenatide, metformin, olanzapine-samidorphan, orlistat, phentermine-topiramate, semaglutide, tirzepatide, topiramate
Learning Objectives
Evaluate evidence-based data regarding treatment approaches to address clinical needs of patients with antipsychotic-associated weight gain.
Implement evidence-based pharmacologic and/or nonpharmacologic strategies for antipsychotic-associated weight gain tailored to individual patient needs based on pertinent medical, psychosocial, family, cultural and socioeconomic issues.
Provide monitoring recommendations for patients treated with antipsychotics and medications to manage antipsychotic-associated weight gain.
Provide pharmacotherapy and disease-specific education for patients treated with antipsychotics and medications to manage associated weight gain.
Continuing Education Credit and Disclosures
Activity Dates:09/27/2024 - 03/27/2025 ACPE Contact Hours: 5 ACPE Number: 0284-0000-24-041-H01-P (Application) Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The From Theory to Practice Case Series product is an application-based program approved for 5 ACPE hours. To receive ACPE credit, pharmacists completing this programming are required to complete an evaluation of the course as well as pass an online examination.
Board Certified Psychiatric Pharmacists (BCPPs) may also receive 5 hours of BCPP Recertification Credit for the From Theory to Practice Case Series upon successful completion of an online examination. BCPP Recertification credit is earned and reported within the year the assessment is successfully completed.
The American Association of Psychiatric Pharmacists is approved as a Professional Development Provider for the Board Certified Psychiatric Pharmacist (BCPP) specialty by the Board of Pharmacy Specialties (BPS). This course is part of a 5 hour BCPP recertification product earned after successful completion of the associated BCPP recertification examination for the full product.
AAPP reports continuing credit for ACPE (CPE Monitor) and BCPP Recertification (BPS) within days of successful exam completion.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH
Kristen N. Gardner, PharmD, BCPP
Clinical Pharmacy Specialist - Behavioral Health
Kaiser Permanente Colorado
Denver, CO
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Biostrategies - one time consultant re:LAIAs (2019)
Educational Grants, Research Grants or Contracts: ACCP PSAP author (2021-2022); ACCP annual meeting speaker (2020)
Rebecca Graham, PharmD, BCPP
Clinical Pharmacy Program Manager - Mental Health and Substance Use
VISN 8 Pharmacy Benefits Management
Orlando, FL
No Relevant Financial Relationships to Disclose
Rania Kattura, PharmD, BCPP, MS
Clinical Pharmacist
Austin State Hospital
Austin, TX
Non-Financial Interests: member of planning committee for the annual UTPsych Update conference in Austin, TX, Volunteer Pharmacist at free clinic in Cedar Park, TX
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.